Dr. Nhiem Tran is a Senior Lecturer in the Department of Applied Chemistry and Environmental Science at RMIT University's School of Science, part of the STEM College. He joined RMIT in 2015 as a Vice Chancellor's Research Fellow after completing his PhD in Physics at Brown University (USA, 2012) and postdoctoral research at Rhode Island Hospital (USA), CSIRO, and the Australian Synchrotron. His research focuses on developing biomaterials for drug delivery, gene therapy, and medical implants, particularly lipid nanoparticles and 3D-printed metallic implants. He leads the Biomaterial Interfaces group, investigating self-assembled lipid nanoparticles for cancer and autoimmune disease treatments. His work has resulted in over 65 high-impact publications and numerous awards, including the RMIT Vice Chancellor's Research Fellowship and the Stein/Bellet Foundation Fellowship. Tran's funding comes from grants such as the ARC Discovery Project, mRNA Victoria, and the CASS Foundation. His research interests span nanomedicine, biomedical engineering, and materials science, with a focus on applications in drug delivery, bacterial infection control, and orthopaedic implants. Education: PhD in Physics (Brown University, 2012) Key Projects: 3D-printed diamond-titanium implants, lipid nanoparticle drug carriers, and antimicrobial coatings. He actively supervises postgraduate research in areas like nanomaterials for drug delivery and biomedical applications.
Professor Shaun Gregory is the Director of the Centre for Biomedical Technologies at Queensland University of Technology (QUT), where he also serves as Co-Director of the Artificial Heart Frontiers Program, Founder and Director of the Heart Hackathon student team competition, and Director of the CardioRespiratory Engineering and Technology Laboratory. He holds appointments in the Faculty of Engineering, School of Mechanical, Medical & Process Engineering. His educational background includes Bachelor, Masters (research), and PhD degrees, all awarded by QUT. He also holds both NHMRC and Heart Foundation fellowships, demonstrating his significant contributions to cardiovascular research. Professor Gregory's research applies a translational approach to cardiovascular engineering with a particular focus on devices used to support or replace the heart. His work brings together multidisciplinary teams of engineering, biomedical science, design, and medicine to develop novel technical solutions for clinically relevant problems. His research has changed clinical practice on numerous occasions and assisted with the regulatory approval of medical devices. His areas of interest include mechanical circulatory support, artificial heart development, cardiovascular device engineering, and hemodynamics. His publication portfolio demonstrates a strong focus on extracorporeal membrane oxygenation (ECMO), ventricular assist devices, and cardiovascular device testing. His recent work has explored computational fluid dynamics in blood flow analysis, novel cannula design for circulatory support, and the hemodynamic effects of various cardiovascular devices. His research often bridges engineering principles with clinical applications, resulting in practical innovations in cardiac support technologies. NHMRC Fellowship Heart Foundation Fellowship President-Elect of the International Society for Mechanical Circulatory Support Professor Gregory has successfully secured more than $65 million in research funding and has published over 100 research articles in his field. He is actively involved in mentoring the next generation of researchers, currently accepting Honours, Masters, and PhD students. His CardioRespiratory Engineering and Technology Laboratory serves as a hub for interdisciplinary research that brings together engineering, biomedical science, and clinical expertise to address critical challenges in cardiovascular medicine.
Mathieu Odijk is a Full Professor at the University of Twente's Faculty of Science and Technology, leading the Integrated Devices and Systems department. His research focuses on microfluidic systems, catalysis, and organ-on-chip platforms, with contributions to UN Sustainable Development Goals through advanced material characterization and biomedical engineering. He has authored over 120 publications and holds an h-index of 27 with 1,820 citations. Expertise: Microfluidics, catalyst particle diagnostics, SERS substrates, organ-on-chip systems, and spectroscopic techniques. Collaborations include Weckhuysen (catalysis), van den Berg (microfluidics), and Meirer (materials science). Key projects: Modular organ-on-chip platforms (STARTER), droplet-based catalyst screening, and real-time reaction monitoring via ATR-IR systems. His research combines nanotechnology and chemical engineering to develop tools for sustainable energy, environmental remediation, and biomedical applications. Recent work includes microreactors for catalyst particle analysis, light-driven urea oxidation for wearable kidney devices, and standardized platforms for organ-on-chip research.
Professor Athina E Markaki serves as Professor of Materials & Biomedical Engineering in the Department of Engineering at the University of Cambridge, leading research in advanced biomaterials and tissue engineering solutions for regenerative medicine with emphasis on vascularization and tubular scaffold development for human conduit replacement. Her academic credentials include a Diploma in Metallurgical Engineering (8.6/10) from the National Technical University of Athens and a PhD in Materials Science from the University of Cambridge. Markaki's research program centers on vascularisation techniques for clinically relevant tissue dimensions and tubular scaffolds to replace diseased or damaged human conduits, integrating biomaterials science with regenerative medicine principles. Key applications span liver tissue engineering, neural crest-derived stem cell differentiation, and vascular graft development, with strong translational focus on orthopaedic and cardiovascular medical devices. Analysis of her recent publications reveals dominant trends in biomimetic scaffold design, particularly collagen-based tubular structures and hydrogel systems for vascularized tissue constructs. Her work demonstrates interdisciplinary convergence of AI-driven retinal assessment, glioblastoma modeling, and self-healing cementitious materials, with consistent emphasis on clinically applicable regenerative solutions for liver, bone, and neural tissues. Her distinguished scientific contributions are recognized by major awards: Rosetrees Trust 2017 Interdisciplinary Award European Research Council (ERC) Starting Grant (2010) Advanced EPSRC Fellowship (2005) De Montfort Award at SET for Britain National Event (2004) Young Scientist Prize 2003 (5th Euromech Solid Mechanics Conference) Multiple academic excellence awards from Greek foundations Markaki directs a well-funded research program including ERC and EPSRC grants, mentoring graduate students in tissue engineering while teaching core engineering curricula covering plastic deformation, fracture mechanics, and medical materials design. Her group maintains strong industry and clinical partnerships to advance regenerative technologies. Her laboratory, accessible via http://www-memti.eng.cam.ac.uk/, specializes in vascularized tissue constructs and tubular scaffolds using laser-based manufacturing, biomimetic design, and hydrogel engineering to address critical challenges in tissue replacement and disease modeling.
Kelsey Swingle is an Assistant Professor of Bioengineering at Rice University, where she leads the Swingle Lab at the intersection of biomaterials science, immune engineering, and reproductive biology. Her research focuses on engineering therapeutic and vaccine technologies with translational potential. Ph.D. in Bioengineering from the University of Pennsylvania B.S.E. in Biomedical Engineering from Case Western Reserve University Dr. Swingle’s research explores the design of lipid nanoparticles (LNPs) and nucleic acid therapeutics for women’s health applications, including pre-eclampsia, preterm birth, and gynecologic cancers. Her work integrates bioengineering principles with immune modulation strategies to develop targeted therapies. The trends in her publications highlight advancements in LNP elasticity optimization for placental mRNA delivery, targeted systemic RNA delivery to the brain, and in utero gene editing applications. Her lab prioritizes interdisciplinary approaches to overcome biological barriers in women’s health. 2025 Solomon R. Pollack Award for Excellence in Graduate Bioengineering Research 2024 Muriel Joan Drew Hege Award for Women in Cellular Immunotherapy Research 2024 Penn Engineering Outstanding Teaching Award 2023 Gordon Research Conference Travel Award 2022 Society for Biomaterials STAR Award 2020 NSF Graduate Research Fellowship The Swingle Lab collaborates with the Texas Medical Center to develop precision nanomedicines. Her team employs in vitro, ex vivo, and in vivo models to study biomaterial interactions with female-specific tissues, emphasizing translational research and inclusive scientific communication.
Prof. Dr. Kathrin Schumann is an Assistant Professor at the Technical University of Munich (TUM), leading the 'Engineering Immune Cells for Therapy' group within the TUM School of Medicine and Health. Her research focuses on CRISPR-based engineering of human immune cells to develop novel therapies for autoimmune and tumor diseases. She holds a doctorate from the Max Planck Institute of Biochemistry and has conducted postdoctoral research at the University of California, San Francisco, under Professors Alex Marson and Jeffrey Bluestone. Dr. Schumann’s academic career includes a Presidential Postdoc Fellowship at Novartis (Basel) and a tenure-track appointment at TUM since 2018. Her work emphasizes genomic editing of T cells to study gene function and improve cell therapy safety. Key research themes include CRISPR-mediated gene silencing, T cell receptor engineering, and HIV-host interaction studies. Education: Bachelor/Master in Biochemistry, University of Tübingen PhD, Max Planck Institute of Biochemistry (Martinsried) Postdoc, University of California, San Francisco (UCSF) Her research has yielded breakthroughs in CRISPR applications for T cell therapy, including PD-1 disruption to enhance anti-tumor efficacy and targeted editing of T cell receptors. Awards include a DFG research grant (2016). Notable achievements include the development of CRISPR ribonucleoprotein platforms for primary T cells and insights into metabolic checkpoints in T cell exhaustion. Her lab collaborates globally to translate CRISPR-based discoveries into clinical therapies.
Dr. Su Ryon Shin is an Assistant Professor in the Division of Engineering in Medicine at Harvard Medical School and Brigham and Women's Hospital (BWH) in Cambridge, MA. She leads an active research laboratory focused on bioengineering, tissue engineering, and regenerative medicine, with particular expertise in 3D bioprinting, biomaterials, and organ-on-a-chip technology. Her research interests span biohybrid robotics, decellularized extracellular matrix, stem cell-based tissue engineering, and volumetric muscle regeneration . Dr. Shin's work integrates advanced biomaterials with cellular systems to create innovative solutions for tissue regeneration and disease modeling. She has pioneered approaches using human stem cell-derived materials for volumetric tissue regeneration and developed biohybrid neuromuscular robots powered by living cardiac muscle cells. Her publication record demonstrates consistent productivity with over 180 publications, including numerous first/senior author papers in high-impact journals like Science Robotics, Advanced Materials, and Nature Reviews Bioengineering . Her work shows a clear progression from fundamental biomaterials development to increasingly complex tissue engineering applications and translational research. Dr. Shin has received significant recognition including being named a 2025 BWH Health & Technology Innovation Awardee , Highly Cited Researcher 2024 by Web of Science, and multiple Stepping Strong Innovator Awards (2015, 2018, 2020). Her research has been featured in Nature Reviews Bioengineering for breakthrough work on biohybrid robots. She actively mentors students and postdocs, with former lab members accepted to prestigious programs like MIT's PhD program in Chemical Engineering. Her collaborative approach is evident through numerous interdisciplinary projects with researchers across Harvard Medical School, BWH, and international institutions.
Dr. Joanna Deaton Bertram is an Assistant Professor in the Thomas Lord Department of Mechanical Engineering and Materials Science at Duke University’s Pratt School of Engineering. She concurrently holds an Assistant Professor appointment in Surgery, underscoring her interdisciplinary commitment to advancing medical robotics. Dr. Bertram leads a research laboratory devoted to the design, modeling, and control of robotic systems for surgical and interventional applications, working closely with Duke’s clinical and engineering communities. Education Ph.D. in Robotics, Georgia Institute of Technology, 2024 M.S. in Mechanical Engineering, Georgia Institute of Technology, 2024 B.S. in Biomedical Engineering, Georgia Institute of Technology, 2018 Research Interests Dr. Bertram’s research program is centered on medical robotics , with particular emphasis on continuum robotics and image-guided interventions . Her work integrates novel mechanical design with advanced control algorithms and smart materials to create robotic systems capable of navigating complex anatomical pathways. A hallmark of her approach is the incorporation of real-time fiber-optic shape and force sensing (using Fiber Bragg Grating technology) to provide surgeons with unprecedented feedback during procedures. Application domains include steerable needles for brachytherapy , robotic guidewires for endovascular surgery , and pediatric neuroendoscopy . Publication Themes Across more than fifteen peer-reviewed articles, Dr. Bertram has systematically advanced the state of the art in surgical robotics , fiber-optic sensing , and robotic system modeling . Her 2024 tutorial on Nitinol and Tungsten tendon attachment techniques provides practical guidance for building highly articulated continuum robots, while her 2023 series on the COAST guidewire robot demonstrates model-based design and simultaneous shape/force sensing for large-deflection medical devices. Earlier work explored 3D-printed patient-specific robotic tools and carbon-nanotube flexible sensors, illustrating a trajectory from fundamental sensor research to full robotic system integration. Scientific Recognition & Collaboration Although no major external awards are explicitly listed, Dr. Bertram’s publications in top-tier venues such as IEEE Robotics and Automation Letters , IEEE Transactions on Medical Robotics and Bionics , and IEEE/ASME Transactions on Mechatronics attest to strong peer recognition. She actively invites motivated graduate students, post-docs, and research staff to join her lab, fostering an open and interdisciplinary environment. Advising & Grants Dr. Bertram’s lab is presently recruiting trainees at all levels. While specific funded grants are not enumerated, her dual departmental appointments and extensive publication record suggest active federal or foundation support. Prospective students and collaborators are encouraged to contact her directly at joanna.d.bertram@duke.edu . Laboratory & Teams Dr. Bertram directs a laboratory within Duke University’s Pratt School of Engineering that collaborates closely with clinicians in the School of Medicine. The group focuses on rapid prototyping of medical devices, in-vitro and ex-vivo validation, and translation of robotic technologies to the operating room.
Suel-Kee Kim is an Associate Research Scientist in Neuroscience at the Yale School of Medicine, Yale University. Their research focuses on neurodevelopment, stem cell biology, and cellular mechanisms underlying neurological disorders. Key areas include neural fate determination from pluripotent stem cells, molecular programs in macaque brain development, and transcriptomic analysis of neural differentiation pathways. Notable contributions include studies on cellular recovery post-ischemia, impaired neurogenesis in congenital hydrocephalus, and retinoic acid's role in prefrontal cortex patterning. Collaborations with leading labs like the Sestan Lab emphasize interdisciplinary approaches in neuroscience and regenerative medicine. Publications highlight innovative work in stem cell microenvironment engineering, forensic transcriptomics of flies, and pancreatic islet differentiation for diabetes therapy. Their research bridges basic science and translational applications in neurology and regenerative medicine.
Robert T. Tranquillo serves as a Distinguished McKnight University Professor in the Department of Biomedical Engineering at the University of Minnesota's College of Science and Engineering. His research focuses on developing biologically-engineered vascular grafts, heart valves, and vein valves using tissue engineering approaches. Notably, his lab has demonstrated that their engineered material, produced by skin cells (fibroblasts), has the capacity to grow, which may transform the treatment of pediatric congenital heart defects. Tranquillo's research interests center on cardiovascular tissue engineering, particularly the development of "off-the-shelf" vascular grafts and heart valves. His lab fabricates tissue-equivalents by entrapping fibroblasts in fibrin gel and constraining cell-mediated gel compaction to create aligned fibrin structures. Using bioreactors, they stimulate cells to replace aligned fibrin with collagenous matrix, creating tubes suitable for surgical implantation. Upon decellularization, these become non-immunogenic replacements that support host recellularization and growth. His current work focuses on transcatheter heart valves and vein valves, combining engineered matrix tubes with stent technology, and conferring hemocompatibility using stem cell and small molecule strategies. A key aspect of his research investigates contact guidance—the ability of cells to sense and align with fibers—which is crucial for creating tissues with prescribed alignment. His publication record shows consistent output in top journals including Nature Communications, Science Translational Medicine, and PNAS, with recent work focusing on contact guidance mechanisms, pediatric valve conduits, and transcatheter valve development. His research demonstrates a clear trajectory from fundamental biomechanics to translational applications in cardiovascular medicine. Distinguished McKnight University Professor (prestigious University of Minnesota honor) Tranquillo has mentored over 40 PhD students and postdocs who have gone on to prominent positions in academia (professors at UCLA, Rutgers, Penn State), industry (Medtronic, Abbott, Boston Scientific), and government (NSF, NRO). His lab has received substantial research funding supporting their work on tissue-engineered cardiovascular replacements. The Tranquillo Research Group maintains an active website detailing their current projects and methodologies. The Tranquillo Research Group operates within the Department of Biomedical Engineering at the University of Minnesota, with laboratory facilities focused on tissue engineering, biomechanics, and cardiovascular device development. Their work bridges fundamental cell-matrix interactions with translational applications for cardiovascular disease treatment.
Dr. Zhi-Ping Feng is a Bioinformatician at the John Curtin School of Medical Research (JCSMR), Australian National University (ANU). Her research focuses on integrating omics data with protein structure-function relationships to study interactions between macromolecules. She has expertise in analyzing genomic and transcriptomic data (e.g., RNA-Seq, ChIP-Seq) and protein structure determination via nuclear magnetic resonance (NMR) spectroscopy. Previously, she held a Senior Research Fellow position at the Walter and Eliza Hall Institute (WEHI) from 2009, working on quality control in omics research and genomic data analysis. Her postdoctoral work at WEHI (2002–2005) involved structural biology of malaria-related proteins, supported by an Australian Postdoctoral Fellowship. She holds a PhD in protein bioinformatics from China and a physics background from Peking University. Education: PhD in Protein Bioinformatics (China) Bachelor’s in Physics, Peking University Research Interests: Her work bridges computational biology and structural biology, with emphasis on: Intrinsically unstructured proteins (IUPs) and their applications in malaria proteomics Omics data integration for disease modeling (e.g., cancer, diabetes, neurodegeneration) Protein-protein interaction networks and structural bioinformatics Publications: Recent work spans cancer immunotherapy, miRNA regulation in retinal degeneration, and T cell biology, with contributions to understanding Wnt signaling in joint replacement complications and genetic fusions in pediatric brain tumors. Awards: Australian Postdoctoral Fellowship (2005) Grants/Teams: Currently affiliated with ANU Bioinformatics Consultancy, supporting translational medical research in immunology, cancer, and genomics. Labs/Teams: Collaborates with the JCSMR’s multidisciplinary teams focusing on biomedical informatics and translational research.
Hani Abdeltawab serves as Academic Casual Staff in the Department of Pharmacy within the Faculty of Medical and Health Sciences at the University of Auckland, New Zealand. Based at Building 503, 85 Park Road, Grafton Campus, they maintain an active research profile with multiple recent publications in pharmaceutical sciences. Dr. Abdeltawab's research focuses on advanced drug delivery systems, particularly poloxamer-based thermoresponsive gels for sustained release applications. Their work spans multiple therapeutic areas including pain management, smoking cessation, and bone regeneration. Key research interests include formulation optimization of injectable gelling systems, modulation of drug release profiles, and stability testing of pharmaceutical admixtures. Analysis of their publication record reveals a strong emphasis on developing sustained-release platforms for various drugs including bupivacaine, ketorolac, nicotine, and lactoferrin. The research demonstrates expertise in polymer science, pharmaceutical formulation, and in vitro/in vivo testing methodologies. Recent work has particularly focused on extending drug release duration while minimizing initial burst effects through strategic formulation modifications. Dr. Abdeltawab has established productive research collaborations across multiple institutions, as evidenced by co-authorship on numerous publications. Their work appears in reputable pharmaceutical journals including the International Journal of Pharmaceutics, Expert Opinion on Drug Delivery, and European Journal of Pharmaceutics and Biopharmaceutics.
Dr. Philipp Fisch is a Researcher affiliated with ETH Zurich's Institute for Biomechanics, specifically within the Tissue Engineering and Biofabrication research group. His work focuses on advancing biofabrication techniques for complex biological structures, particularly in cartilage regeneration and auricular reconstruction. Key areas of expertise include 3D bioprinting, hydrogel development, and patient-specific tissue engineering solutions. Research Interests: Dr. Fisch's research integrates biomaterial science, cell biology, and engineering principles to create functional tissues. Central themes include: Development of biodegradable materials for cartilage and bone regeneration Optimization of bioprinting parameters for clinical translation Integration of patient-derived cells for personalized therapies Investigation of immune responses in transplanted biofabricated tissues Recent Work Trends: His publications emphasize translational applications, such as auricular reconstruction for microtia patients and immunocompetent animal model validation. Thematic clusters include hydrogel-based systems, anisotropic material design, and inflammation-resistant tissue engineering strategies. Labs/Teams: Active contributor to the Institute for Biomechanics' biofabrication initiatives, collaborating on projects involving eluting mold casting, multi-layered tissue transplants, and advanced scaffold development.
Ellen Arruda is the Tim Manganello/BorgWarner Department Chair and Maria Comninou Collegiate Professor of Mechanical Engineering at the University of Michigan. She holds joint appointments in Biomedical Engineering and Macromolecular Science and Engineering. Her research bridges biomechanics and materials science, focusing on soft tissue mechanics and polymer behavior. PhD (Mechanical Engineering, MIT, 1992) MS (Engineering Mechanics, Penn State, 1988) BS (Engineering Science, Penn State, 1985) Her research spans biomechanics , soft tissue engineering , and polymer mechanics , with applications to knee ligament replacement , impact-resistant materials , and brain-protective helmets . She utilizes full-field displacement mapping and computational modeling to analyze tissue and polymer responses under extreme conditions. Recent publications emphasize knee ligament characterization , nanocomposite design , and impact mitigation . Her work has attracted major funding from DARPA , NSF , and NIH , among others. National Academy of Engineering (2017) A.C. Eringen Medal (2021) Nadai Medal (2019) Distinguished Faculty Achievement Award (2014) As Principal Investigator of the Soft Tissue and Polymer Mechanics Lab , she leads a team exploring tissue engineering strategies and advanced material solutions. Her lab has developed 3D scaffold-free constructs for bone-ligament interfaces and blast-resistant composites .
Carlijn Bouten is Full Professor of Cell-Matrix Interactions in Cardiovascular Regeneration at Eindhoven University of Technology. She leads the Soft Tissue Engineering & Mechanobiology group, investigating cellular interactions with extracellular environments in tissue growth, adaptation, and regeneration. Her research develops biodegradable heart valve prostheses that enable in vivo tissue regeneration, applying tissue engineering approaches to cardiovascular medicine. Professor Bouten holds an MSc from Vrije Universiteit Amsterdam and a PhD from TU/e. She completed postdoctoral research at Université Laval and University of London before joining TU/e's faculty. She directs the national Gravitation program 'Materials-Driven Regeneration' and received an ERC Advanced Grant for cardiac tissue organization research. Research Focus: Her interdisciplinary program spans: Mechanobiological cues in tissue regeneration Development of living heart valve replacements Advanced biomaterials for cardiovascular applications In vitro models for tissue development Soft robotic systems for cardiac assistance Recent publications demonstrate innovations in biohybrid devices, standardized biomaterial testing, and novel tissue patterning techniques. Her work integrates engineering, materials science, and clinical translation through collaborations with medtech spin-offs. Leadership and Recognition: Fellow of the European Alliance for Medical and Biological Engineering President-elect of the Heart Valve Society Member of AcademiaNet for Outstanding Female Scientists Recipient of NWO VICI grant and Aspasia award She leads multinational consortia in regenerative medicine and teaches courses on heart/blood physiology and regeneration. Her lab develops model systems spanning cellular to tissue levels to quantify mechanobiological processes.
